Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Indian pharma companies are challenging Novo Nordisk's semaglutide patents in court, which could pave the way for cheaper ...

Proven Weight Loss Results You’ve likely seen stories of people losing 15–20 percent of their body weight with Ozempic. Those aren’t just isolated anecdotes – they come from clinical trials.

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

Ozempic is typically only covered by insurance when prescribed to treat type 2 diabetes, or type 2 diabetes that coexists ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

Ozempic, the brand name for semaglutide, has become a hot topic in recent months. Originally FDA-approved for managing insulin levels in type 2 diabetes patients, its off-label use for weight ...

Initially approved to treat Type 2 diabetes, Ozempic and Mounjaro also can help people with Type 1 diabetes lose weight and control their blood sugar levels, a new study finds.

New studies link Ozempic and Wegovy to rare vision loss, but experts say the risk is quite small. Here’s what you need to ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

New weight loss medicine seen as an alternative to Ozempic, GLP-1 drugs Dr. Mahsa Tehrani discusses how patients use medication to help them lose weight on 'America Reports.' ...